Literature DB >> 21323798

Pharmacoeconomic impact of obesity in severe haemophilia children on clotting factor prophylaxis in a single institution.

S Majumdar, A Ostrenga, R D Latzman, C Payne, Q Hunt, A Morris, R Iyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21323798     DOI： 10.1111/j.1365-2516.2010.02462.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  6 in total

1.  Prophylaxis use among males with haemophilia B in the United States.

Authors:  M Ullman; Q C Zhang; S D Grosse; M Recht; J M Soucie
Journal:  Haemophilia       Date:  2017-08-06       Impact factor: 4.287

2.  The role of disease severity in influencing body mass index in people with haemophilia: a single-institutional cross-sectional study.

Authors:  M McNamara; A Antun; C L Kempton
Journal:  Haemophilia       Date:  2013-10-14       Impact factor: 4.287

3.  Association of overweight and obesity with the use of self and home-based infusion therapy among haemophilic men.

Authors:  M Ullman; Q C Zhang; D Brown; A Grant; J M Soucie
Journal:  Haemophilia       Date:  2013-11-22       Impact factor: 4.287

4.  Modeling of Body Weight Metrics for Effective and Cost-Efficient Conventional Factor VIII Dosing in Hemophilia A Prophylaxis.

Authors:  Alanna McEneny-King; Pierre Chelle; Severine Henrard; Cedric Hermans; Alfonso Iorio; Andrea N Edginton
Journal:  Pharmaceutics       Date:  2017-10-17       Impact factor: 6.321

Review 5.  Treatment adherence in hemophilia.

Authors:  Courtney D Thornburg; Natalie A Duncan
Journal:  Patient Prefer Adherence       Date:  2017-09-27       Impact factor: 2.711

6.  Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?

Authors:  Quentin Allard; Zoubir Djerada; Claire Pouplard; Yohann Repessé; Dominique Desprez; Hubert Galinat; Birgit Frotscher; Claire Berger; Annie Harroche; Anne Ryman; Claire Flaujac; Pierre Chamouni; Benoît Guillet; Fabienne Volot; Jean Szymezak; Philippe Nguyen; Yoann Cazaubon
Journal:  Pharmaceutics       Date:  2020-04-21       Impact factor: 6.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.